# BinaxNow COVID-19 IgG Rapid Test Device and Antibody Self Test

> **NCT04959760** · NA · COMPLETED · sponsor: **Abbott Rapid Diagnostics Jena GmbH** · enrollment: 263 (actual)

## Conditions studied

- COVID-19 Respiratory Infection

## Interventions

- **DIAGNOSTIC_TEST:** The BinaxNOW™ Antibody Tests measure IgG antibodies against SARS-CoV-2.

## Key facts

- **NCT ID:** NCT04959760
- **Lead sponsor:** Abbott Rapid Diagnostics Jena GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-03
- **Primary completion:** 2022-01-20
- **Final completion:** 2022-01-20
- **Target enrollment:** 263 (ACTUAL)
- **Last updated:** 2022-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04959760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04959760, "BinaxNow COVID-19 IgG Rapid Test Device and Antibody Self Test". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04959760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*